Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Escape of human immunodeficiency virus type 1 from broadly neutralizing antibodies is not associated with a reduction of viral replicative capacity in vitro.

Virology - 5 Jul 2007

Quakkelaar Esther D, Bunnik Evelien M, van Alphen Floris P J, Boeser-Nunnink Brigitte D M, van Nuenen Ad C, Schuitemaker Hanneke

Abstract excerpt

Although the majority of primary HIV-1 variants can be neutralized by broadly neutralizing antibodies such as b12, 2G12, 2F5 and 4E10, resistance to these antibodies has been reported as well. The ability of the broadly neutralizing antibodies to inhibit a variety of viruses suggests that their e...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Drug Resistance, Viral
Share to Epitopes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Antibodies

Share to HIV Infections

Share to Neutralization Tests

Share to Virulence

Share to Virus Replication

Source

Identifiers

PMID: 17355886
DOI: 10.1016/j.virol.2007.02.011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17355886-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Escape of human immunodeficiency virus type 1 from broadly neutralizing antibodies is not associated with a reduction of viral replicative capacity in vitro.PMID 17355886Read ↗

HIV-1 mutants escaping neutralization by the human antibodies 2F5, 2G12, and 4E10: in vitro experiments versus clinical studies.Semantic proximity Read ↗

Broadly neutralizing antibodies developed by an HIV-positive elite neutralizer exact a replication fitness cost on the contemporaneous virus.Semantic proximity Read ↗

Immune escape by human immunodeficiency virus type 1 from neutralizing antibodies: evidence for multiple pathways.Semantic proximity Read ↗

Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies.Semantic proximity Read ↗

Lack of ADCC Breadth of Human Nonneutralizing Anti-HIV-1 AntibodiesSemantic proximity Read ↗

Neutralizing Antibody Responses against Autologous and Heterologous Viruses in Acute versus Chronic Human Immunodeficiency Virus (HIV) Infection: Evidence for a Constraint on the Ability of HIV To Completely Evade Neutralizing Antibody ResponsesSemantic proximity Read ↗

Human immunodeficiency virus type 1 variants isolated from single plasma samples display a wide spectrum of neutralization sensitivity.Semantic proximity Read ↗

Effects of neutralizing antibodies on escape from CD8+ T-cell responses in HIV-1 infection.Semantic proximity Read ↗

Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees.Semantic proximity Read ↗

Human immunodeficiency virus type 1 superinfection occurs despite relatively robust neutralizing antibody responses.Semantic proximity Read ↗

Impairment of CD4(+) T cell responses during chronic virus infection prevents neutralizing antibody responses against virus escape mutants.Semantic proximity Read ↗

Resistance of HIV-1 to the broadly HIV-1-neutralizing, anti-carbohydrate antibody 2G12.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.